Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 18056629.
- Also identified by PMC identifier 2154426.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Elevated expression and activation of the focal adhesion kinase (FAK) occurs in a large proportion of human breast cancers. Although several studies have implicated FAK as an important signaling molecule in cell culture systems, evidence supporting a role for FAK in mammary tumor progression is lacking. To directly assess the role of FAK in this process, we have used the Cre/loxP recombination system to disrupt FAK function in the mammary epithelium of a transgenic model of breast cancer. Using this approach, we demonstrate that FAK expression is required for the transition of premalignant hyperplasias to carcinomas and their subsequent metastases. This dramatic block in tumor progression was further correlated with impaired mammary epithelial proliferation. These observations provide direct evidence that FAK plays a critical role in mammary tumor progression.
Medical subject headings
- Carcinoma
- Focal Adhesion Protein-Tyrosine Kinases
- Mammary Neoplasms, Experimental